Company Overview

LeMaitre Vascular, Inc. is a medical device company focused on the design, manufacture, and global distribution of products used in the treatment of peripheral vascular disease. The company operates within the vascular surgery and endovascular therapy segments of the broader medical technology industry. Its product portfolio is primarily used by vascular surgeons, interventional radiologists, and cardiologists to address conditions affecting arteries and veins outside the heart and brain.

The company’s core revenue drivers include vascular grafts, catheters, biologic patches, and arterial embolectomy devices, with a strategic emphasis on products that support open vascular surgery rather than fully disposable, high-volume devices. LeMaitre Vascular differentiates itself through a focused niche strategy, disciplined acquisition of complementary technologies, and a decentralized manufacturing and distribution model. Founded in 1983, the company evolved from a small specialty device developer into a globally diversified vascular products supplier through organic product development and targeted acquisitions.

Business Operations

LeMaitre Vascular generates revenue through the sale of its vascular surgery and endovascular products, organized across multiple product families rather than formal reporting segments. Key business lines include Vascular Grafts, Biologic Patches, Catheters & Introducers, Arterial Embolectomy Devices, and Endovascular Tools. The company sells directly to hospitals and clinics in most major markets, supported by a combination of direct sales forces and third-party distributors.

Operations span both domestic and international markets, with manufacturing conducted in the United States and select international facilities. LeMaitre controls proprietary manufacturing processes for several core products, particularly biologic and polymer-based grafts and patches. The company operates through numerous wholly owned subsidiaries that manage regional sales, regulatory approvals, and localized distribution, supporting its strategy of proximity to surgeons and healthcare systems.

Strategic Position & Investments

LeMaitre Vascular’s strategy centers on steady, profitable growth through selective acquisitions of small to mid-sized vascular device businesses that align with its surgeon-focused portfolio. The company consistently reinvests capital into expanding its product breadth, particularly in biologic materials, access devices, and niche surgical tools. Acquisitions are typically integrated into existing product lines while maintaining operational discipline and margin focus.

Notable investments include the acquisition of CardioMed Supplies, Vascutek’s dialysis access graft line, Artegraft, and P.A.S. Port, each expanding LeMaitre’s presence in biologic grafts, dialysis access, and implantable vascular devices. The company continues to invest in incremental innovation, regulatory expansion, and surgeon education rather than large-scale platform technologies or high-risk emerging sectors.

Geographic Footprint

LeMaitre Vascular is headquartered in Burlington, Massachusetts, and maintains a significant operational and commercial presence across North America, Europe, Asia-Pacific, Latin America, and the Middle East. International markets account for a substantial portion of total revenue, reflecting the company’s long-standing emphasis on global diversification.

The company operates through direct subsidiaries in key markets such as Germany, France, Italy, Spain, Japan, China, and Australia, while utilizing distributors in smaller or emerging regions. This geographic structure allows LeMaitre to navigate local regulatory environments effectively and tailor sales strategies to regional clinical practices.

Leadership & Governance

LeMaitre Vascular is led by an executive team with deep experience in medical devices, operations, and international commercialization. The company emphasizes a leadership philosophy centered on capital discipline, long-term value creation, and surgeon-centric innovation, with governance practices aligned to public company standards and regulatory compliance.

Key executives include:

• George W. LeMaitre – Founder
• George W. LeMaitre, Jr. – Chairman of the Board
• Patrick J. LeMaitre – Chief Executive Officer
• Tracy J. Kemp – Chief Financial Officer
• David J. Roberts – President
• William J. Wright – Chief Operating Officer

The leadership team maintains a conservative financial posture, prioritizing profitability, return on invested capital, and incremental global expansion over aggressive scaling or speculative investments.